Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 30-38

  Rekart, Michael L ^a   Gilbert, Mark ^b   Meza, Rafael ^b,e   Kim, Paul H ^b   Chang, Michael ^d   Money, Deborah M ^c   Brunham, Robert C ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c Women's Health Research Institute   (Canada)

^d MINISTRY OF HEALTH   (Canada)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Arrested immunity; Chlamydia; Ectopic pregnancy; PID; Public health programs

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA; CHLAMYDIAL URETHRITIS; CHLAMYDIASIS; ECTOPIC PREGNANCY; FEMALE; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; TREND STUDY;

ADOLESCENT; ADULT; AGE FACTORS; BRITISH COLUMBIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; OUTPATIENTS; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, ECTOPIC; PUBLIC HEALTH; URETHRITIS; YOUNG ADULT;

EID: 84872917888     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis644     Document Type: Article

References (47)

1. Scholes D, Satterwhite CL, Onchee Y, Fine D, Weinstock H, Berman S. Long-term trends in Chlamydia trachomatis infections and related outcomes in a US managed care population. Sex Transm Dis 2012; 39:81-8.
2. British Columbia Centre for Disease Control. STI/HIV annual report 2010. http://www.bccdc.ca/util/about/annreport/default.htm. Accessed 3 July 2012.
3. European Centre for Disease Prevention and Control. Chlamydia control in Europe (June 2009). http://www.ecdc.europa.eu/en/ Publications/publications/ 0906-GUI-Chlamydia-Control-in-Europe. pdf. Accessed 23 November 2009.
4. Australian Bureau of Statistics. 2008 yearbook Australia. http://www. abs.gov.au/ausstats/ABS.nsf/0/A07A9723F922549FCA2573D20010777D? opendocument. Accessed 10 November 2009.
5. Rekart ML, Brunham RC. Epidemiology of chlamydial control: are we losing ground? Sex Transm Infect 2008; 84:87-91.
6. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfectiion. J Infect Dis 2005; 192:1836-44.
7. Lyytikainen E, Kaasila M, Hiltunen-Back E, et al. A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003. BMC Infect Dis 2008; 8:169.
8. CDC. CDC Grand Rounds: Chlamydia Prevention: Challenges and strategies for reducing disease burden and sequelae. MMWR 2011; 60:370-3.
9. Satterwhite CL, Grier A, Patzer R, Weinstock H, Howards PP, Kleinbaum D. Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008. Sex Transm Dis 2011; 38:989-94.
10. Datta SD, Torrone E, Kruszon-Moran D, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis 2012; 39:92-6.
11. Satterwhite CL, Gray AM, Berman S, Weinstock H, Kleinbaum D, Howards PP. Chlamydia trachomatis infections among women attending prenatal clinics: United States, 2004-2009. Sex Transm Dis 2102; 39:416-20.
12. Rekart ML, Brunham RC. Stable Chlamydia prevalence does not exclude increasing burden of disease. Sex Transm Dis 2012; 39:239.
13. Satterwhite CL, Weinstock H. Response to stable Chlamydia prevalence does not exclude increasing burden of disease. Sex Transm Dis 2012; 39:239-40.
14. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of Chlamydia control. Sex Transm Dis 2008; 35:53-4.
15. British Columbia Centre for Disease Control. Communicable disease control manual. Chapter 5: sexually transmitted infections. 2010. http://www.bccdc.ca/ dis-cond/comm-manual/CDManualChap5.htm. Accessed 10 July 2012.
16. McCreary Centre Society. A picture of health: highlights from the 2008 BC adolescent health survey. http://www.mcs.bc.ca/ahs-reports. Accessed 22 September 2011.
17. Sutton MY, Sternberg M, Zaidi A, Louis ME St., Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32:778-84.
18. Bohm MK, Newman L, Satterwhite CL, Tao G, Weinstock HS. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010; 37:131-6.
19. Van Den Eeden SK, Shan J, Bruce C, Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol 2005; 105:1052-7.
20. Statistical yearbook of Sweden. Official statistics of Sweden. http://www.socialstyrelsen.se/english/international/statistics. Accessed 19 November 2009.
21. Low N, Egger M, Simms I, Herrmann B. Contrasting trends in rates of genital chlamydial infection and ectopic pregnancy in South East Thames Region, England and Uppsala County, Sweden: ecological study. J Epidemiol Community Health 1999; 53:438-9.
22. Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316:1776-80.
23. Ward H, Cassell J, Williams S, Aylin P. Hospital indicators of poor health - Dr. Foster's notes. BMJ 2005; 330:1173.
24. Simms I, Fleming DM, Lowndes CM, Smith GE, Chapman RS. Surveillance of sexually transmitted diseases in general practice: a description of trends in the Royal College of General Practitioners Weekly Returns Service between 1994 and 2001. Int J STD AIDS 2006; 17:693-8.
25. Australian Institute of Health and Welfare. Interactive national hospital data: separation, patient day and average length of stay statistics by principal diagnosis, Australia, 1993-4 to 1997-98 and 1998-99 to 2007-08. http://www.aihw.gov.au/hospitals/datacubes/index.cfm. Accessed 19 November 2009.
26. Chen MY, Fairley CK, Donovan B. Discordance between trends in Chlamydia notifications and hospital admission rates for Chlamydia related diseases in New South Wales, Australia. Sex Transm Infect 2005; 81:318-22.
27. Chen MY, Pan Y, Britt H, Donovan B. Trends in clinical encounters for pelvic inflammatory disease and epididymitis in a national sample of Australian general practices. Int J STD AIDS 2006; 17:384-6.
28. Bender N, Herrmann B, Andersen B, et al. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: crossnational study. Sex Transm Infect 2011; 87:601-8.
29. Medical Services Plan of British Columbia. http://www.health.gov.bc. ca/msp/index.html. Accessed 12 December 2009.
30. Canadian Institute for Health Research Information. Discharge Abstract Database. http://www.cihi.ca/cihiweb/dispPage.jsp?cw-page= services-dad-e. Accessed 12 December 2009.
31. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19:335-51
32. correction: 2001;20:655.
33. Box GEP, Jenkins GM. Time series analysis: forecasting and control. 3rd ed. Upper Saddle River, NJ: Prentice Hall, 1994.
34. Granger CWJ. Investigating causal relations be econometric models and cross-spectral methods. Econometrica 1969; 37:424-38.
35. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, MacKenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-7.
36. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 1997; 65:2175-82.
37. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7:717-25.
38. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99:77-87.
39. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11:44-51.
40. Paavonen J, Weström L, Eschenbach DA. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually Transmitted Diseases. New York: McGraw Hill Medical, 2008:1017-50.
41. Oakeshott P, Kerry S, Aghaizu A, et al. Randomized controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340:c1642 .
42. Demianczuk NN, Van den Hof MC. The use of first trimester ultrasound. J Obstet Gynaecol Can 2003; 25:864-9.
43. Brunham RC, Peeling R, Maclean I, Kosseim ML, Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis 1992; 165:1076-81.
44. Dixon RE, Ramsey KH, Schripsema JH, Sanders KM, Ward SM. Time-dependent disruption of oviduct pacemaker cells by Chlamydia infection in mice. Biol Reprod 2010; 83:244-53.
45. Ratelle S, Yokoe D, Blejan C, Whelan M, et al. Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID). Sex Transm Dis 2003; 30:866-70.
46. Gottleib SL, Martin DH, Xu F, Byrne GL, Brunham RC. Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis 2010; 201(Suppl 2):S190-204.
47. Golden MR. Expedited partner therapy for sexually transmitted diseases. Clin Infect Dis 2005; 41:630-3.